La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Ethanol Tolerance Affects Endogenous Adenosine Signaling in Mouse Hippocampus.

Identifieur interne : 000360 ( Main/Exploration ); précédent : 000359; suivant : 000361

Ethanol Tolerance Affects Endogenous Adenosine Signaling in Mouse Hippocampus.

Auteurs : Dali Zhang [Canada] ; Wei Xiong [Canada] ; Michael F. Jackson [Canada] ; Fiona E. Parkinson [Canada]

Source :

RBID : pubmed:27189965

Abstract

Ethanol has many pharmacological effects, including increases in endogenous adenosine levels and adenosine receptor activity in brain. Ethanol consumption is associated with both positive and negative health outcomes, but tolerance to the behavioral effects of ethanol can lead to increased consumption, which increases the risk of negative health outcomes. The present study was performed to test whether a 7-day treatment with ethanol is linked to reduced adenosine signaling and whether this is a consequence of reduced ecto-5'-nucleotidase activity. Wild-type (CD73(+/+)) and ecto-5'-nucleotidase-deficient (CD73(-/-)) mice were treated with ethanol (2 g/kg) or saline for 7 days. In CD73(+/+) mice, repeated ethanol treatment reduced the hypothermic and ataxic effects of acute ethanol, indicating the development of tolerance to the acute effects of ethanol. In CD73(+/+) mice, this 7-day ethanol treatment led to increased hippocampal synaptic activity and reduced adenosine A1 receptor activity under both basal and low Mg(2+) conditions. These effects of ethanol tolerance were associated with an 18% decrease in activity of ecto-5'-nucleotidase activity in hippocampal cell membranes. In contrast, ethanol treatment was not associated with changes in synaptic activity or adenosine signaling in hippocampus from CD73(-/-) mice. These data indicate that ethanol treatment is associated with a reduction in adenosine signaling through adenosine A1 receptors in hippocampus, mediated, at least in part, via reduced ecto-5'-nucleotidase activity.

DOI: 10.1124/jpet.116.232231
PubMed: 27189965


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Ethanol Tolerance Affects Endogenous Adenosine Signaling in Mouse Hippocampus.</title>
<author>
<name sortKey="Zhang, Dali" sort="Zhang, Dali" uniqKey="Zhang D" first="Dali" last="Zhang">Dali Zhang</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName>
<settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Xiong, Wei" sort="Xiong, Wei" uniqKey="Xiong W" first="Wei" last="Xiong">Wei Xiong</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName>
<settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jackson, Michael F" sort="Jackson, Michael F" uniqKey="Jackson M" first="Michael F" last="Jackson">Michael F. Jackson</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName>
<settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E" last="Parkinson">Fiona E. Parkinson</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba, Canada Fiona.Parkinson@umanitoba.ca.</nlm:affiliation>
<country wicri:rule="url">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName>
<settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27189965</idno>
<idno type="pmid">27189965</idno>
<idno type="doi">10.1124/jpet.116.232231</idno>
<idno type="wicri:Area/PubMed/Corpus">000208</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000208</idno>
<idno type="wicri:Area/PubMed/Curation">000208</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000208</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000208</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000208</idno>
<idno type="wicri:Area/Ncbi/Merge">001F78</idno>
<idno type="wicri:Area/Ncbi/Curation">001F78</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001F78</idno>
<idno type="wicri:Area/Main/Merge">000361</idno>
<idno type="wicri:Area/Main/Curation">000360</idno>
<idno type="wicri:Area/Main/Exploration">000360</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Ethanol Tolerance Affects Endogenous Adenosine Signaling in Mouse Hippocampus.</title>
<author>
<name sortKey="Zhang, Dali" sort="Zhang, Dali" uniqKey="Zhang D" first="Dali" last="Zhang">Dali Zhang</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName>
<settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Xiong, Wei" sort="Xiong, Wei" uniqKey="Xiong W" first="Wei" last="Xiong">Wei Xiong</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName>
<settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jackson, Michael F" sort="Jackson, Michael F" uniqKey="Jackson M" first="Michael F" last="Jackson">Michael F. Jackson</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName>
<settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E" last="Parkinson">Fiona E. Parkinson</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba, Canada Fiona.Parkinson@umanitoba.ca.</nlm:affiliation>
<country wicri:rule="url">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName>
<settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The Journal of pharmacology and experimental therapeutics</title>
<idno type="eISSN">1521-0103</idno>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Ethanol has many pharmacological effects, including increases in endogenous adenosine levels and adenosine receptor activity in brain. Ethanol consumption is associated with both positive and negative health outcomes, but tolerance to the behavioral effects of ethanol can lead to increased consumption, which increases the risk of negative health outcomes. The present study was performed to test whether a 7-day treatment with ethanol is linked to reduced adenosine signaling and whether this is a consequence of reduced ecto-5'-nucleotidase activity. Wild-type (CD73(+/+)) and ecto-5'-nucleotidase-deficient (CD73(-/-)) mice were treated with ethanol (2 g/kg) or saline for 7 days. In CD73(+/+) mice, repeated ethanol treatment reduced the hypothermic and ataxic effects of acute ethanol, indicating the development of tolerance to the acute effects of ethanol. In CD73(+/+) mice, this 7-day ethanol treatment led to increased hippocampal synaptic activity and reduced adenosine A1 receptor activity under both basal and low Mg(2+) conditions. These effects of ethanol tolerance were associated with an 18% decrease in activity of ecto-5'-nucleotidase activity in hippocampal cell membranes. In contrast, ethanol treatment was not associated with changes in synaptic activity or adenosine signaling in hippocampus from CD73(-/-) mice. These data indicate that ethanol treatment is associated with a reduction in adenosine signaling through adenosine A1 receptors in hippocampus, mediated, at least in part, via reduced ecto-5'-nucleotidase activity.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
<region>
<li>Manitoba</li>
</region>
<settlement>
<li>Winnipeg</li>
</settlement>
<orgName>
<li>Université du Manitoba</li>
</orgName>
</list>
<tree>
<country name="Canada">
<region name="Manitoba">
<name sortKey="Zhang, Dali" sort="Zhang, Dali" uniqKey="Zhang D" first="Dali" last="Zhang">Dali Zhang</name>
</region>
<name sortKey="Jackson, Michael F" sort="Jackson, Michael F" uniqKey="Jackson M" first="Michael F" last="Jackson">Michael F. Jackson</name>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E" last="Parkinson">Fiona E. Parkinson</name>
<name sortKey="Xiong, Wei" sort="Xiong, Wei" uniqKey="Xiong W" first="Wei" last="Xiong">Wei Xiong</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000360 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000360 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:27189965
   |texte=   Ethanol Tolerance Affects Endogenous Adenosine Signaling in Mouse Hippocampus.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:27189965" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022